查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541748

2024-2032 年按产品类型（人工重要器官、医学仿生学）、应用（医院、诊所等）和地区分類的人造重要器官和医疗仿生学市场报告

Artificial Vital Organs and Medical Bionics Market Report by Product Type (Artificial Vital Organs, Medical Bionics), Application (Hospitals, Clinics, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球人工重要器官和医疗仿生市场规模达到470亿美元。呼吸系统疾病、肝硬化、心臟肝衰竭的盛行率不断上升，极易患器官疾病的老年人口不断增加，以及各种技术进步是推动市场发展的一些关键因素。

人工重要器官，通常称为人工器官或生物人工器官，是旨在模仿人体内自然器官功能的人造装置。这些设备的开发目的是作为功能障碍或失效的生物器官的临时或永久替代品，帮助患者维持基本的身体功能，在某些情况下甚至增强这些功能。另一方面，医学仿生学是医学科学和工程领域，专注于生物和人工成分的开发和整合，以恢復或增强人体功能。

目前，各种疾病的盛行率显着增加，包括呼吸系统疾病、肝硬化以及心臟、肾臟和肝臟衰竭。这种激增与不断扩大的医疗保健产业密切相关，并成为市场成长的重要催化剂。此外，全球老年人口的不断增加特别容易患器官相关疾病，这对市场的扩张做出了巨大贡献。此外，全功能人工心臟、肝臟、肺臟、尿道、气管、肾臟等创新产品的持续开发，正在对市场动态产生正面影响。此外，主要市场参与者正在研发（R＆D）方面进行大量投资，旨在透过工程组织引入器官再生的尖端方法。这种持续的创新正在培养一个充满希望的市场前景。除此之外，由于生物人工器官的出现，可以提高存活率并加快患者康復速度，对人工器官的需求不断增长。移植桥和危急医疗病例復健桥等挽救生命技术的实施进一步推动了这种不断增长的需求，进一步加强了市场成长。

人造重要器官与医疗仿生学市场趋势/驱动因素：

呼吸系统疾病、肝硬化和器官衰竭的盛行率上升

慢性阻塞性肺病（COPD）和肺部感染等呼吸系统疾病的盛行率显着增加。患有严重呼吸问题的患者通常需要人工肺或其他辅助装置才能充分呼吸。此外，由于过量饮酒、病毒性肝炎感染和非酒精性脂肪肝等多种因素，包括肝硬化在内的肝臟疾病增加。在晚期，肝硬化可能需要肝臟移植，而人工肝臟可以作为移植的桥樑，甚至是长期的解决方案。此外，心臟和肝臟衰竭是全世界严重的健康问题。由于人口老化、肥胖和生活方式选择等因素，充血性心臟衰竭和末期肝病等疾病正在增加。人工心臟和肝臟支持系统在患者等待移植时提供挽救生命的解决方案或作为永久支持选择方面发挥着至关重要的作用。

全球老年人口不断增加

全球人口格局正在转向人口老化。由于自然老化过程，老年人更容易出现器官疾病，这使他们成为人工重要器官干预的关键人群。此外，老年人更容易罹患慢性病，包括心血管疾病、呼吸系统疾病和肾臟疾病。这些情况通常需要人工心臟、肺或肾臟等干预措施来控製或改善患者的生活品质。起搏器和人工耳蜗等医学仿生学也常用于老年人，以解决与年龄相关的健康问题。人工重要器官和医学仿生学对于延长和改善这些老年人的生命至关重要，使他们能够在晚年享受更好的生活品质。

各种技术进步

医疗技术的进步显着改善了人造重要器官和医学仿生学的设计、功能和有效性。此外，人工心臟和人工肺等全功能人工器官的开发能力也得到了增强，使患者能够过着更积极的生活。此外，尖端材料和生物工程技术的结合导致了高度模仿自然器官的生物人工器官的诞生，降低了排斥风险并改善了患者的整体治疗效果。此外，医疗科技产业的领导者正在大力投资研发活动，旨在改善人造重要器官和医学仿生学。这些投资导致开发出更复杂的设备、增强的材料和改进的手术技术，所有这些都有助于改善患者的治疗效果。

本报告回答的关键问题

  • 全球人工重要器官和医学仿生市场有多大？ 2024-2032年全球人工重要器官和医疗仿生市场的预期成长率为何？
  • 推动全球人工重要器官和医学仿生市场的关键因素是什么？
  • COVID-19对全球人工重要器官及医学仿生市场有何影响？
  • 依产品类型划分，全球人工重要器官和医学仿生市场的细分情况如何？
  • 全球人工重要器官及医学仿生市场的重点区域有哪些？
  • 全球人造重要器官和医疗仿生学市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球人造重要器官与医疗仿生市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 人工重要器官
    • 市场趋势
    • 关键环节
      • 人工肝
      • 人工心臟
      • 人工胰臟
      • 人工肾
      • 人工肺
      • 制氧机
    • 市场预测
  • 医学仿生学
    • 市场趋势
    • 关键环节
      • 仿生肢体
      • 视觉仿生学
      • 耳朵仿生学
      • 外骨骼
      • 脑仿生学
      • 心臟瓣膜
      • 心臟仿生学
    • 市场预测

第 7 章：市场区隔：按应用

  • 医院
    • 市场趋势
    • 市场预测
  • 诊所
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abiomed
    • BiVACOR Inc
    • CARMAT
    • Cirtec Medical
    • Edwards Lifesciences
    • Ekso Bionics Holdings Inc.
    • Nikkiso Co. Ltd.
    • Second Sight Medical Products Inc
    • SynCardia Systems LLC (Picard Medical Inc.)
Product Code: SR112024A6458

The global artificial vital organs and medical bionics market size reached US$ 47.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 72.1 Billion by 2032, exhibiting a growth rate (CAGR) of 4.72% during 2024-2032. The rising prevalence of respiratory ailments, cirrhosis, and heart and liver failures, the increasing geriatric population that is highly prone to organ disorders, and various technological advancements represent some of the key factors driving the market.

Artificial vital organs, often referred to as artificial organs or bioartificial organs, are man-made devices designed to mimic the functions of natural organs within the human body. These devices are developed to serve as temporary or permanent replacements for malfunctioning or failed biological organs, helping patients maintain essential bodily functions and, in some cases, even enhancing them. On the other hand, medical bionics is a field of medical science and engineering that focuses on the development and integration of biological and artificial components to restore or enhance the functioning of the human body.

Currently, there is a notable surge in the prevalence of various medical conditions, including respiratory disorders, cirrhosis, as well as heart, kidney, and liver failures. This surge is closely tied to the expanding healthcare sector and serves as a significant catalyst for market growth. Furthermore, the increasing elderly population, which is particularly susceptible to organ-related ailments worldwide, is making a substantial contribution to the market's expansion. Moreover, the continuous development of innovative products, such as fully functional artificial hearts, livers, lungs, urethras, windpipes, and kidneys, is exerting a positive impact on market dynamics. Additionally, major market players are making substantial investments in research and development (R&D) endeavors, aimed at introducing cutting-edge methods of organ regeneration through engineered tissues. This ongoing innovation is fostering a promising outlook for the market. Besides this, there is a rising demand for artificial organs, driven by the emergence of bioartificial organs that offer improved survival rates and faster patient recovery. This growing demand is further propelled by the implementation of life-saving technologies like the bridge to transplant and the bridge to recovery in critical medical cases, further reinforcing market growth.

Artificial Vital Organs and Medical Bionics Market Trends/Drivers:

Rising prevalence of respiratory ailments, cirrhosis, and organ failures

There has been a notable increase in the prevalence of respiratory ailments such as chronic obstructive pulmonary disease (COPD) and lung infections. Patients with severe respiratory issues often require artificial lungs or other assistive devices to breathe adequately. Moreover, liver diseases, including cirrhosis, have seen a rise due to various factors like excessive alcohol consumption, viral hepatitis infections, and non-alcoholic fatty liver disease. In advanced stages, cirrhosis may necessitate liver transplantation, and artificial livers can serve as a bridge to transplantation or even a long-term solution. Besides, heart and liver failures are significant health concerns worldwide. Conditions like congestive heart failure and end-stage liver disease are on the rise due to factors such as an aging population, obesity, and lifestyle choices. Artificial hearts and liver support systems play a crucial role in providing life-saving solutions while patients await transplantation or as a permanent support option.

Increasing geriatric population across the globe

The global demographic landscape is shifting toward an aging population. Elderly individuals are more susceptible to organ disorders due to the natural aging process, making them a key demographic for artificial vital organ interventions. Besides, the elderly population is more prone to chronic medical conditions, including cardiovascular diseases, respiratory ailments, and kidney disorders. These conditions frequently require interventions such as artificial hearts, lungs, or kidneys to manage or improve the patient's quality of life. Medical bionics, such as pacemakers and cochlear implants, are also commonly used in elderly individuals to address age-related health issues. Artificial vital organs and medical bionics become crucial in extending and improving the lives of these elderly individuals, allowing them to enjoy a better quality of life in their later years.

Various technological advancements

Advancements in medical technology have significantly improved the design, functionality, and effectiveness of artificial vital organs and medical bionics. Moreover, full-functioning artificial organs, such as artificial hearts and lungs, have been developed with enhanced capabilities, allowing patients to lead more active lives. Besides, the integration of cutting-edge materials and bioengineering techniques has led to the creation of bioartificial organs that closely mimic natural organs, reducing the risk of rejection and improving overall patient outcomes. Additionally, leading players in the medical technology industry are investing heavily in research and development activities aimed at improving artificial vital organs and medical bionics. These investments result in the development of more sophisticated devices, enhanced materials, and improved surgical techniques, all of which contribute to better patient outcomes.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global artificial vital organs and medical bionics market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type and application.

Breakup by Product Type:

Artificial Vital Organs

Artificial Liver

Artificial Heart

Artificial Pancreas

Artificial Kidney

Artificial Lungs

Oxygenators

Medical Bionics

Bionic Limbs

Vision Bionics

Ear Bionics

Exoskeletons

Brain Bionics

Heart Valves

Cardiac Bionics

Artificial vital organs represent the most used product type

The report has provided a detailed breakup and analysis of the market based on the product type. This includes artificial vital organs (artificial liver, artificial heart, artificial pancreas, artificial kidney, artificial lungs, and oxygenators) and medical bionics (bionic limbs, vision bionics, ear bionics, exoskeletons, brain bionics, heart valves, and cardiac bionics). According to the report, artificial vital organs represented the largest segment.

Artificial vital organs are designed to mimic the functions of natural vital organs such as the heart, lungs, kidneys, and liver. These devices are often used as a last resort when a patient's natural organs fail. They serve a life-saving function, providing crucial support to sustain a patient's life until a transplant becomes available or the natural organs recover. Moreover, there is a consistently high demand for artificial vital organs due of the prevalence of organ failure and the limited availability of organ donors. Individuals worldwide suffer from conditions that can lead to organ failure, and the demand for replacement organs far exceeds the supply. Artificial vital organs bridge this gap by offering a viable solution to patients in critical need.

Breakup by Application:

Hospitals

Clinics

Others

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes hospitals, clinics, and others.

Hospitals are a primary application for artificial vital organs and medical bionics. In these healthcare facilities, artificial vital organs such as artificial hearts, lungs, and kidneys are often used to support patients with organ failure while they await transplants. Additionally, medical bionics, including devices like cochlear implants and bionic limbs, may be provided to patients in hospital settings to improve their quality of life and functional capabilities.

Clinics, including specialized medical centers and outpatient facilities, play a crucial role in the application of artificial vital organs and medical bionics. These settings are where patients may receive diagnosis, consultation, and follow-up care related to these advanced medical technologies. Clinics often offer services related to the assessment, fitting, and maintenance of medical bionics, making them essential in the continuum of care.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America, particularly the United States and Canada, boasts a highly advanced healthcare infrastructure with state-of-the-art medical facilities and research institutions. This infrastructure fosters innovation and the development of cutting-edge medical technologies, including artificial vital organs and medical bionics. Besides, the region is a global hub for medical research and development. Leading universities, medical centers, and private companies collaborate to push the boundaries of medical science. This collaborative environment accelerates the creation and commercialization of medical bionics and artificial vital organs. Moreover, the region has well-established regulatory bodies, such as the Food and Drug Administration (FDA) in the United States and Health Canada, which ensure the safety and efficacy of medical devices. A robust regulatory framework provides confidence to investors, manufacturers, and healthcare providers, encouraging the development and adoption of medical bionics.

Competitive Landscape:

The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are heavily investing in R&D to develop innovative and advanced artificial vital organs and medical bionics. They focus on improving the performance, durability, and safety of these devices, as well as reducing their size and enhancing compatibility with the human body. They are also expanding their product portfolios to cover a broader range of medical bionics and artificial organs. This diversification allows them to address a wider array of medical conditions and patient needs. Besides, companies are acquiring or merging with other companies in the industry to expand capabilities, gain access to new technologies, and increase market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abiomed

BiVACOR Inc

CARMAT

Cirtec Medical

Edwards Lifesciences

Ekso Bionics Holdings Inc.

Nikkiso Co. Ltd.

Second Sight Medical Products Inc

SynCardia Systems LLC (Picard Medical Inc.)

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

Edwards LifeSciences Corporation invested $35 million in an exclusive right to acquire Corvia Medical, Inc., the developer of the world's first transcatheter device designed to treat heart failure with preserved or mid-range ejection fraction.

In February 2020, Ekso Bionics Holdings, Inc. teamed up with Kindred Healthcare, LLC to test EksoNR, a robotic exoskeleton, in their long-term acute care hospitals.

Key Questions Answered in This Report

  • 1. How big is the global artificial vital organs and medical bionics market?
  • 2. What is the expected growth rate of the global artificial vital organs and medical bionics market during 2024-2032?
  • 3. What are the key factors driving the global artificial vital organs and medical bionics market?
  • 4. What has been the impact of COVID-19 on the global artificial vital organs and medical bionics market?
  • 5. What is the breakup of the global artificial vital organs and medical bionics market based on the product type?
  • 6. What are the key regions in the global artificial vital organs and medical bionics market?
  • 7. Who are the key players/companies in the global artificial vital organs and medical bionics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Vital Organs and Medical Bionics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Artificial Vital Organs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Artificial Liver
      • 6.1.2.2 Artificial Heart
      • 6.1.2.3 Artificial Pancreas
      • 6.1.2.4 Artificial Kidney
      • 6.1.2.5 Artificial Lungs
      • 6.1.2.6 Oxygenators
    • 6.1.3 Market Forecast
  • 6.2 Medical Bionics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bionic Limbs
      • 6.2.2.2 Vision Bionics
      • 6.2.2.3 Ear Bionics
      • 6.2.2.4 Exoskeletons
      • 6.2.2.5 Brain Bionics
      • 6.2.2.6 Heart Valves
      • 6.2.2.7 Cardiac Bionics
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abiomed
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BiVACOR Inc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 CARMAT
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Cirtec Medical
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Edwards Lifesciences
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Ekso Bionics Holdings Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Nikkiso Co. Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Second Sight Medical Products Inc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 SynCardia Systems LLC (Picard Medical Inc.)
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Artificial Vital Organs and Medical Bionics Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Artificial Vital Organs and Medical Bionics (Artificial Vital Organs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Artificial Vital Organs and Medical Bionics (Artificial Vital Organs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Artificial Vital Organs and Medical Bionics (Medical Bionics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Artificial Vital Organs and Medical Bionics (Medical Bionics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Artificial Vital Organs and Medical Bionics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Artificial Vital Organs and Medical Bionics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Artificial Vital Organs and Medical Bionics (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Artificial Vital Organs and Medical Bionics (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Artificial Vital Organs and Medical Bionics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Artificial Vital Organs and Medical Bionics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: North America: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: North America: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: United States: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: United States: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Canada: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Canada: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Asia-Pacific: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Asia-Pacific: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: China: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: China: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Japan: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Japan: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: India: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: India: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: South Korea: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: South Korea: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Australia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Australia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Indonesia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Indonesia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Europe: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Europe: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Germany: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Germany: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: France: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: France: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: United Kingdom: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: United Kingdom: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Italy: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Italy: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Spain: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Spain: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Russia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Russia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Latin America: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Latin America: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Brazil: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Brazil: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Mexico: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Mexico: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market: Breakup by Country (in %), 2023
  • Figure 65: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Global: Artificial Vital Organs and Medical Bionics Industry: SWOT Analysis
  • Figure 67: Global: Artificial Vital Organs and Medical Bionics Industry: Value Chain Analysis
  • Figure 68: Global: Artificial Vital Organs and Medical Bionics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Vital Organs and Medical Bionics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Artificial Vital Organs and Medical Bionics Market: Competitive Structure
  • Table 6: Global: Artificial Vital Organs and Medical Bionics Market: Key Players